US2023012637A1PendingUtilityA1

Simulation system and program product

Assignee: XENLON CORPPriority: Dec 19, 2019Filed: Dec 8, 2020Published: Jan 19, 2023
Est. expiryDec 19, 2039(~13.4 yrs left)· nominal 20-yr term from priority
G16H 50/20G16H 50/30G16H 50/50
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A simulation system is provided that gives new awareness to doctors regarding medical diagnosis, and a program product for attaining said system. A simulation system performs a simulation related to a specific disease or symptom for which a major index for diagnosis is assigned, includes: a database created on the basis of inspection results collected from a large number of subjects; a smartphone or a personal computer through which a freely selectable value is entered for each of a plurality of inspection items contained in the inspection results; and a server that collates the value of each inspection item having been entered, with the database, and derives a score regarding the specific disease or symptom, wherein the inspection item regarding the major index is preliminarily excluded from the inspection items allowed for entry.

Claims

exact text as granted — not AI-modified
1 . A simulation system that performs a simulation related to a specific disease or symptom for which a major index for diagnosis is assigned, the simulation system comprising:
 a database created on the basis of inspection results collected from a large number of subjects;   an entry section through which a freely selectable value is entered for each of a plurality of inspection items contained in the inspection results; and   a calculation unit that collates the value of each inspection item having been entered through the entry section, with the database, and derives a score regarding the specific disease or symptom,   the inspection item regarding the major index being preliminarily excluded from the inspection items allowed for entry through the entry section.   
     
     
         2 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is diabetes, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is HbA1c (hemoglobin a-one-c).   
     
     
         3 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is at least either polycythemia or erythrocythemia, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is at least one of red blood cell count, hemoglobin or hematocrit.   
     
     
         4 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is eosinophilia, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is eosinophil count.   
     
     
         5 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is high triglycerides, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is triglyceride.   
     
     
         6 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is high LDL cholesterol, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is LDL cholesterol.   
     
     
         7 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is myocardial infarction, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is cardiac troponin I (cTnI).   
     
     
         8 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is hepatitis B, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is HBV-DNA quantification.   
     
     
         9 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is hepatitis C, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is HCV-RNA quantification.   
     
     
         10 . The simulation system according to  claim 1 ,
 wherein the specific disease or symptom is renal dysfunction, and   the inspection item regarding the major index, being preliminarily excluded from the inspection items allowed for entry through the entry section, is estimated GFRcreat.   
     
     
         11 . The simulation system according to  claim 1 ,
 wherein a standard range is assigned for each inspection item which is at least a part of the inspection items allowed for entry through the entry section,   the score derived by the calculation unit varies in response to change in value of each inspection item entered through the entry section, and   when a value to be entered regarding one inspection item varies, a value that gives the best score may fall out of the standard range.   
     
     
         12 . A program product that causes a computer to perform a simulation related to a specific disease or symptom for which a major index for diagnosis is assigned, the program product causing the computer to execute:
 an entry process entering a freely selectable value for each of a plurality of inspection items contained in inspection results regarding the specific disease or symptom; and   an output process outputting a score regarding the specific disease or symptom, derived by collating the value of each inspection item entered by the entry process, with a database created on the basis of the inspection results collected from a large number of subjects,   the inspection item regarding the major index being preliminarily excluded from the inspection items allowed for entry by the entry process.

Join the waitlist — get patent alerts

Track US2023012637A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.